Association of kidney function, vitamin D deficiency, and circulating markers of mineral and bone disorders in CKD.

BACKGROUND Vitamin D (25 hydroxyvitamin D [25(OH)D]) deficiency is common in patients with chronic kidney disease (CKD). Neither the relation of this deficiency to the decrease in glomerular filtration rate (GFR) nor the effects on CKD mineral and bone disorders (MBD) are clearly established. STUDY DESIGN Cross-sectional analysis of baseline data from a prospective cohort, the NephroTest Study. SETTING & PARTICIPANTS 1,026 adult patients with all-stage CKD not on dialysis therapy or receiving vitamin D supplementation. PREDICTORS For part 1, measured GFR (mGFR) using (51)Cr-EDTA renal clearance; for part 2, 25(OH)D deficiency at <15 ng/mL. OUTCOMES & MEASUREMENTS For part 1, 25(OH)D deficiency and several circulating MBD markers; for part 2, circulating MBD markers. RESULTS For part 1, the prevalence of 25(OH)D deficiency was associated inversely with mGFR, ranging from 28%-51% for mGFR ≥60-<15 mL/min/1.73 m(2). It was higher in patients of African origin; those with obesity, diabetes, hypertension, macroalbuminuria, and hypoalbuminemia; and during winter. After adjusting for these factors, ORs for 25(OH)D deficiency increased from 1.4 (95% CI, 0.9-2.3) to 1.4 (95% CI, 0.9-2.1), 1.7 (95% CI, 1.1-2.7), and 1.9 (95% CI, 1.1-3.6) as mGFR decreased from 45-59 to 30-44, 15-29, and <15 (reference, ≥60) mL/min/1.73 m(2) (P for trend = 0.02). For part 2, 25(OH)D deficiency was associated with higher age-, sex-, and mGFR-adjusted ORs of ionized calcium level <1.10 mmol/L (2.6; 95% CI, 1.2-5.9), 1,25 dihydroxyvitamin D concentration <16.7 pg/mL (1.8; 95% CI, 1.3-2.4), hyperparathyroidism (1.8; 95% CI, 1.3-2.4), and serum C-terminal cross-linked collagen type I telopeptides concentration >1,000 pg/mL (1.6; 95% CI, 1.0-2.6). It was not associated with hyperphosphatemia (phosphate >1.38 mmol/L). LIMITATIONS Cross-sectional analysis of the data prevents causal inferences. CONCLUSIONS 25(OH)D deficiency is related independently to impaired mGFR. Both mGFR decrease and 25(OH)D deficiency are associated with abnormal levels of circulating MBD biomarkers.

[1]  B. Kestenbaum,et al.  25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  R. Heaney.  Lessons for nutritional science from vitamin D. , 1999, The American journal of clinical nutrition.

[3]  J. Gallagher,et al.  Dietary calcium and vitamin D intake in elderly women: effect on serum parathyroid hormone and vitamin D metabolites. , 1998, The American journal of clinical nutrition.

[4]  D. Oliver,et al.  Vitamin D Insufficiency and Deficiency in Chronic Kidney Disease , 2004, American Journal of Nephrology.

[5]  M. Chonchol,et al.  25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. , 2007, Kidney international.

[6]  N. Fujii,et al.  The impact of diabetes mellitus on vitamin D metabolism in predialysis patients. , 2009, Bone.

[7]  G. Eknoyan,et al.  Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). , 2006, Kidney international.

[8]  C. Christiansen.  Chronic renal failure and vitamin D metabolites: a status report. , 1983, Journal of steroid biochemistry.

[9]  Bertram L Kasiske,et al.  The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. , 2011, Kidney international.

[10]  S. Draibe,et al.  Vitamin D status of chronic kidney disease patients living in a sunny country. , 2008, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[11]  H. DeLuca,et al.  Cloning of the human 1 alpha,25-dihydroxyvitamin D-3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements. , 1995, Biochimica et biophysica acta.

[12]  Tom Greene,et al.  Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate , 2006, Annals of Internal Medicine.

[13]  Y. Seino,et al.  Evaluation of vitamin D-binding protein and vitamin D metabolite loss in children on continuous ambulatory peritoneal dialysis. , 1992, Bone and mineral.

[14]  C. Christiansen,et al.  Serum concentrations of vitamin D metabolites in different degrees of impaired renal function. Estimation of renal and extrarenal secretion rate of 24,25-dihydroxyvitamin D. , 1985, Nephron.

[15]  M. Holick.  Vitamin D deficiency. , 2007, The New England journal of medicine.

[16]  Keith C. Norris,et al.  Chronic kidney disease, hypovitaminosis D, and mortality in the United States. , 2009, Kidney international.

[17]  I. Elmadfa,et al.  Status of calcium and vitamin D of different population groups in Austria. , 2000, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[18]  E. Ishimura,et al.  [Vitamin D deficiency/insufficiency in patients with chronic kidney disease stage 3 and 4 -- current concept and its therapeutic strategy]. , 2004, Clinical calcium.

[19]  Hiroyuki Tanaka.  [Pathogenesis and treatment of Vitamin D deficiency]. , 2007, Clinical calcium.

[20]  S. Booth,et al.  Vitamins K and D status in stages 3-5 chronic kidney disease. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[21]  G. Jones,et al.  In vivo metabolism of the vitamin D analog, dihydrotachysterol. Evidence for formation of 1 alpha,25- and 1 beta,25-dihydroxy-dihydrotachysterol metabolites and studies of their biological activity. , 1993, The Journal of biological chemistry.

[22]  M. Holick.  Optimal Vitamin D Status for the Prevention and Treatment of Osteoporosis , 2007, Drugs & aging.

[23]  C. Mathieu,et al.  Vitamin D: a pleiotropic hormone. , 2010, Kidney international.

[24]  M. Horowitz,et al.  Vitamin D Metabolites and Calcium Absorption in Severe Vitamin D Deficiency , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  J. Gallagher,et al.  Relationship between vitamin D, parathyroid hormone, and bone health. , 2011, The Journal of clinical endocrinology and metabolism.

[26]  R. Heaney.  Optimal Vitamin D Status , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  S. Takeda,et al.  Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[28]  B. Hollis,et al.  Defective photoproduction of cholecalciferol in normal and uremic humans. , 1984, The Journal of nutrition.

[29]  P. Lips,et al.  Determinants of vitamin D status in patients with hip fracture and in elderly control subjects. , 1987, The American journal of clinical nutrition.

[30]  N. Powe,et al.  25-hydroxyvitamin D levels, race, and the progression of kidney disease. , 2009, Journal of the American Society of Nephrology : JASN.

[31]  J. Halpert,et al.  CYP3A4 is a vitamin D-24- and 25-hydroxylase: analysis of structure function by site-directed mutagenesis. , 2005, The Journal of clinical endocrinology and metabolism.

[32]  Keith C. Norris,et al.  K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[33]  S. Moe,et al.  Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[34]  H. Koeffler,et al.  The role of the vitamin D endocrine system in health and disease. , 1989, The New England journal of medicine.

[35]  J. Kuusisto,et al.  Diverse associations of 25‐hydroxyvitamin D and 1,25‐dihydroxy‐vitamin D with dyslipidaemias , 2010, Journal of internal medicine.

[36]  A. Levin,et al.  Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease? , 2005, Kidney international.

[37]  L. Cuppari,et al.  Hypovitaminosis D in chronic kidney disease patients: prevalence and treatment. , 2009, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[38]  M. Holick,et al.  Factors that influence the cutaneous synthesis and dietary sources of vitamin D. , 2007, Archives of biochemistry and biophysics.

[39]  H. Bischoff-Ferrari,et al.  Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. , 2004, The American journal of medicine.

[40]  V. Jorgetti,et al.  Vitamin D status in a sunny country: where has the sun gone? , 2010, Clinical nutrition.

[41]  P. Delmas,et al.  The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects. , 1988, The Journal of clinical endocrinology and metabolism.

[42]  I. Reid,et al.  Prophylaxis against vitamin D deficiency in the elderly by regular sunlight exposure. , 1986, Age and ageing.

[43]  Y. Seino,et al.  Serum phosphate, parathyroid hormone and vitamin D metabolites in patients with chronic renal failure: effect of aluminum hydroxide administration. , 1985, Nephron.

[44]  P. Houillier,et al.  Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. , 2005, Journal of the American Society of Nephrology : JASN.

[45]  F. Leblond,et al.  Reduced hepatic synthesis of calcidiol in uremia. , 2010, Journal of the American Society of Nephrology : JASN.

[46]  A. Levin,et al.  Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. , 2007, Kidney international.

[47]  J. Pietrek.  [Vitamin D in kidney diseases]. , 1976, Polskie Archiwum Medycyny Wewnetrznej.

[48]  Henrik Vorum,et al.  An Endocytic Pathway Essential for Renal Uptake and Activation of the Steroid 25-(OH) Vitamin D3 , 1999, Cell.

[49]  R. Freaney,et al.  Secondary hyperparathyroidism in elderly people: combined effect of renal insufficiency and vitamin D deficiency. , 1993, The American journal of clinical nutrition.

[50]  C. Zoccali,et al.  Vitamin D levels and patient outcome in chronic kidney disease. , 2009, Kidney international.

[51]  Tom Greene,et al.  Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. , 2007, Clinical chemistry.

[52]  A. Norman.  Sunlight, season, skin pigmentation, vitamin D, and 25-hydroxyvitamin D: integral components of the vitamin D endocrine system. , 1998, The American journal of clinical nutrition.

[53]  J. W. Kim,et al.  Dysregulation of renal vitamin D metabolism in the uremic rat. , 2010, Kidney international.

[54]  M. Holick,et al.  Redefining vitamin D insufficiency , 1998, The Lancet.

[55]  J. Achard,et al.  Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol? , 1999, Kidney international.

[56]  J. Weisel,et al.  Endocrine functions of bone in mineral metabolism regulation. , 2008, The Journal of clinical investigation.